US EditionPublished • loading... • Updated
Quick takes: Death toll from USAID cuts, withdrawal of chikungunya vaccine, funding for updated Ebola vaccine
Summary by University of Minnesota Twin Cities…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Ixchiq Vaccine for Chikungunya Virus Pulled Following At Least One Death
Vaccine removed from market after a growing number of reports of chikungunya-like side effects, which resulted in at least one fatal event. After being granted accelerated approval by U.S. federal health regulators, the Ixchiq vaccine was pulled from the U.S. market this week due to reports of more than 20 recipients experiencing serious side effects. Followi…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
